Cassava Sciences, Inc. (SAVA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

23.53

-2.18

(-8.48%)

At close: 04:00PM EDT

23.85

+0.32

(+1.36%)

After hours:

05:58PM EDT

Loading interactive chart...

Simply Wall St.
The three-year returns have been massive for Cassava Sciences (NASDAQ:SAVA) shareholders despite underlying losses increasing
While Cassava Sciences, Inc. (NASDAQ:SAVA) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 22%...
Thomson Reuters StreetEvents
Q4 2022 Lexicon Pharmaceuticals Inc Earnings Call
Q4 2022 Lexicon Pharmaceuticals Inc Earnings Call
GlobeNewswire
Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates
In Q2 2023, We Expect to Complete Patient Dosing for our Cognition Maintenance Study in Alzheimer’s disease.In Q3 2023, We Expect to Announce Results of our Cognition Maintenance Study.In Q4 2023, We Expect to Complete Patient Enrollment for our Phase 3 Studies of Simufilam in Alzheimer’s disease.Mid-year 2023, We Expect an Independent Third Party to Present Evidential Data for The Biological Activity of Simufilam Outside of Neurodegeneration.Cash And Cash Equivalents Were $201 Million at Decemb